Michael J Emch

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 2

Top Topics

Endoplasmic Reticulum

Chemotherapy Induced

Estrogen Receptor

Long Noncoding Rna

Top Venues

NPJ breast cancer

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Esther P B Rodman, Michael J Emch, Xiaonan Hou, Archit Bajaj, Nicole A Pearson, August J John, Yamillie Ortiz, Adam D Bass, Saloni Singh, Gustavo Baldassarre, Scott H Kaufmann, S John Weroha, John R Hawse
Lestaurtinib's antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancer. bioRxiv : the preprint server for biology (2024)
Kirsten G M Aspros, Jodi M Carter, Tanya L Hoskin, Vera J Suman, Malayannan Subramaniam, Michael J Emch, Zhenqing Ye, Zhifu Sun, Jason P Sinnwell, Kevin J Thompson, Xiaojia Tang, Esther P B Rodman, Xiyin Wang, Adam W Nelson, Igor Chernukhin, Feda H Hamdan, Elizabeth S Bruinsma, Jason S Carroll, Martin E Fernandez-Zapico, Steven A Johnsen, Krishna R Kalari, Zhenlin Huang, Roberto A Leon-Ferre, Fergus J Couch, James N Ingle, Matthew P Goetz, John R Hawse
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer. NPJ breast cancer 8 (1) (2022)